Biomarkers in systemic lupus erythematosus - II. Markers of disease activity

被引：118
作者：
Illei, GG [1 ]
Tackey, E [1 ]
Lapteva, L [1 ]
Lipsky, PE [1 ]
机构：
[1] NIAMSD, NIH, DHHS, Bethesda, MD 20892 USA
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 07期
关键词：
D O I：
10.1002/art.20345
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2048 / 2065
页数：18
相关论文
共 179 条
[1]   CORRELATION AND PREDICTIVE ACCURACY OF CIRCULATING IMMUNE-COMPLEXES WITH DISEASE-ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ABRASS, CK ;
NIES, KM ;
LOUIE, JS ;
BORDER, WA ;
GLASSOCK, RJ .
ARTHRITIS AND RHEUMATISM, 1980, 23 (03) :273-282
[2]   CORRELATION BETWEEN SERUM LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ADERKA, D ;
WYSENBEEK, A ;
ENGELMANN, H ;
COPE, AP ;
BRENNAN, F ;
MOLAD, Y ;
HORNIK, V ;
LEVO, Y ;
MAINI, RN ;
FELDMANN, M ;
WALLACH, D .
ARTHRITIS AND RHEUMATISM, 1993, 36 (08) :1111-1120
[3]   EVALUATION OF SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR AS AN INDICATOR OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
AIRO, P ;
BRAGA, S ;
PRATI, E ;
BRUGNONI, D ;
BETTINZIOLI, M ;
GORLA, R ;
CATTANEO, R .
CLINICAL RHEUMATOLOGY, 1992, 11 (01) :97-100
[4]   Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus [J].
Al-Maini, MH ;
Mountz, JD ;
Al-Mohri, HA ;
El-Ageb, EM ;
Al-Riyami, BM ;
Svenson, KLG ;
Zhou, T ;
Richens, ER .
LUPUS, 2000, 9 (02) :132-139
[5]   DECREASED PRODUCTION OF AND RESPONSE TO INTERLEUKIN-2 BY CULTURED LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALCOCERVARELA, J ;
ALARCONSEGOVIA, D .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (06) :1388-1392
[6]  
Amerio P, 2002, CLIN EXP RHEUMATOL, V20, P535
[7]   Characterization of CD3+CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus:: activation markers [J].
Anand, A ;
Dean, GS ;
Quereshi, K ;
Isenberg, DA ;
Lydyard, PM .
LUPUS, 2002, 11 (08) :493-500
[8]   Production of IL-1β, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE [J].
Andersen, LS ;
Petersen, J ;
Svenson, M ;
Bendtzen, K .
AUTOIMMUNITY, 1999, 30 (04) :235-242
[9]   Increased bioactive TNF in human systemic lupus erythematosus:: associations with cell death [J].
Aringer, M ;
Feierl, E ;
Steiner, G ;
Stummvoll, GH ;
Höfler, E ;
Steiner, CW ;
Radda, I ;
Smolen, JS ;
Graninger, WB .
LUPUS, 2002, 11 (02) :102-108
[10]   Serum interleukin-15 is elevated in systemic lupus erythematosus [J].
Aringer, M ;
Stummvoll, GH ;
Steiner, G ;
Köller, M ;
Steiner, CW ;
Höfler, E ;
Hiesberger, H ;
Smolen, JS ;
Graninger, WB .
RHEUMATOLOGY, 2001, 40 (08) :876-881
12345678910